'We are building medtech that reaches the last citizen'

GE HealthCare, which has its largest R&D centre located in Bengaluru—employing 2,000+ engineers and holding over 1,250 patents—is heavily invested in AI, using it to enhance medical imaging quality, improve workflow efficiency, and support clinical decision-making.

- 

While the company plans to invest ₹8,000 crore by 2029 in manufacturing and local R&D, its partnerships with institutes like AIIMS, Indian Institute of Science and Tata Memorial Centre, reflect a focused strategy to co-create scalable solutions that meet the country's diverse healthcare needs.

Girish Raghavan, CTO – Women's Health & X-Ray and VP, Engineering at GE HealthCare Technology Centre India, speaks to Sudhir Chowdhary on the company's tech priorities and key trends in the healthcare industry. Excerpts:

What are the current expansion plans when it comes to capacity?

The MedTech sector is called the 'Sunrise sector' for a reason—it is poised for exponential growth, with projections indicating India's global market share could rise from 1.65% to 10–12% over the next 25 years.

This trajectory is backed by rising public health expenditure and an increasing push for self-reliance in MedTech manufacturing.

India is at the forefront of becoming a MedTech hub, leading innovation and investment in healthcare.

Wipro GE Healthcare is among the first MedTech companies to 'Make in India—for India and the world.

Since inception, the company has invested over $4 billion in R&D and manufacturing in India.

In 2024, we committed an investment of ₹8,000 crore in manufacturing output & local R&D over 5 years.